Loading stock data…
Quantum X Labs Inc. (QXL)
$5.59-0.10 (-1.76%)
Market ClosedLast close Jun 29
Quantum X Labs Inc., through its subsidiaries, focuses on quantum technology, digital advertising and computing, and enterprise artificial intelligence (AI) solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quantum X Labs Inc. in the Technology sector is trading at $5.59 with a market capitalization of $62M. The stock is currently 27% below its 52-week high of $7.70, remaining 113.4% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $353,000↑ | -$6.16M↓ | $2.72M↑ | $2.28M↑ | $529,000 |
| Gross Profit | $221,000↑ | -$123,000↓ | $584,000↑ | $401,000↑ | $395,000 |
| Operating Income | -$550,000↓ | $1.81M↑ | -$1.26M↑ | -$1.77M↓ | -$55,000 |
| Net Income | -$605,000↓ | -$566,000↑ | -$3.39M↑ | -$11.66M↓ | -$3.67M |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Quantum X Labs Inc., through its subsidiaries, focuses on quantum technology, digital advertising and computing, and enterprise artificial intelligence (AI) solutions. The company develops and owns quantum computing technology as well as a quantum er...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$61.81M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-75.08%
Volume
Today's trading volume
65,552
Recent News
Zacks Initiates Coverage of Quantum X With Underperform Recommendation
Discover why Zacks issues an "Underperform" rating for QXL, being the first on Wall Street to initiate coverage on the stock. Learn why liquidity concerns, persistent losses, funding dependence and a weakening legacy business overshadow the company's promising quantum computing ambitions.
Top Midday Gainers
CervoMed (CRVO) received a notice of allowance from the US Patent and Trademark Office for a patent
Quantum X Labs Launches Integrated Quantum Computing Program Combining Its Clinical Trials Data Analysis Quantum Algorithm and Its Quantum Error Correction Decoder
Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X” or the “Company”), an advanced technologies company, today announced the launch of a new integrated quantum computing program that combines the company’s proprietary quantum algorithms for clinical trial data analysis, as part of our CliniQuantum platform, with its advanced Quantum Error Correction (QECC) Decoder technology. The initiative is designed to maximize computational accuracy and reliability by using the company’s quantum algorithm across multiple quantum computing environments combined with its decoder in order to optimize a path toward scalable, fault-tolerant quantum applications.
Quantum X Labs and IQCC, a Quantum Machines Company, Sign Strategic Collaboration Agreement to Evaluate AI-Based Quantum Error Correction on Quantum Infrastructure
Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X Labs” or the “Company”), an advanced quantum technologies company, and IQCC, a Quantum Machines company, today announced the signing of a strategic cooperation agreement, under which Quantum X Labs will evaluate its AI-based quantum error-correction technology on Quantum Machines' quantum control infrastructure. The primary objective is to run Quantum X Labs' proprietary AI-driven error correction algorithm in a fully integrated hardware-software environment.